04-01-2018 дата публикации
Номер: US20180003723A1
Принадлежит:
Methods and compositions for risk detection, early diagnosis, prognosis, and monitoring of sleepiness in an individual by measuring the amount of specific biomarkers present in a bodily fluid and comparing them to a reference level of biomarkers in a sample from a healthy person, a person previously diagnosed with sleepiness, or an earlier sample from the individual of interest. 1. A method of diagnosing sleepiness , comprising:(a) collecting a saliva sample from an individual suspected of suffering a sleep disorder;(b) applying the saliva sample to a solid support on which at least two agents, each of which binds to a different single biomarker selected from arginine, creatine, dihomo-linoleate, tyrosine, beta-endorphin, chromogranin A, annexin I, BDNF, 3-methyl-1-oxo-butyrate, or linolenate have been affixed, and wherein each agent binds to the different single biomarker to form a measurable complex of a single biomarker;(c) measuring the measurable complex of each of the different single biomarkers to create an individual biomarker profile; and an arginine reference level greater than about 0.32 μmol/ml,', 'a creatine reference level greater about 0.47 μmol/ml,', 'a dihomo-linoleate reference level greater than about 34 μmol/ml,', 'a tyrosine reference level greater than about 0.57 μmol/ml,', 'a beta-endorphin reference level greater than about 1490 pg/ml,', 'a BDNF reference level greater than about 488 pg/ml,', 'a 3-methyl-oxobutyrate reference level greater than about 52 μmol/ml,', 'a linoleate reference level greater than about 36 μmol/ml,', 'chromogranin A reference level greater than about 3.3 μmol/mg protein, and', 'an annexin I reference level greater than about 55 ng/ml., '(d) comparing the individual biomarker profile to reference levels for each of the different single biomarkers, wherein the individual biomarker profile meeting two or more criteria in a group of criteria is indicative of the sleep disorder, the group of criteria consisting of2. The ...
Подробнее